Bridging Medical Knowledge: Jenburkt Pharmaceuticals Ltd and NIMHANS Launch First-Ever Neuropathy Masterclass Series
Jenburkt Pharmaceuticals Limited, a 40-year-old pharmaceutical organization listed on the Bombay Stock Exchange and apioneer ...
Hosted on MSN14h
Stock to buy in 2025: 30% upside! BSE 100 share down 17% on YTD; Do you own?
Brokerage house InCred is bullish over a BSE 100 stock that corrected by 17 per cent on YTD. The BSE 100 stock moreover ...